| Literature DB >> 25921453 |
Fereidoun Abtin1, Robert D Suh2, Leyla Nasehi3, Simon X Han3, William Hsu3, Mathew Quirk3, Scott Genshaft3, Antony J Gutierrez3, Robert B Cameron3.
Abstract
Thymoma is the most common primary tumor of the anterior mediastinum and often recurs after initial surgical resection. In this case series, percutaneous cryoablation, a locally ablative technique, was used to treat 25 mediastinal and pleural recurrent thymoma lesions in five patients. Safety and short-term efficacy data were collected. In 23 percutaneous cryoablations (92%), there were no or minimal complications. One serious complication, myasthenia gravis flare, occurred. Over the duration of follow-up (median, 331 d), 18 of 20 ablated lesions (90%) showed no evidence of local recurrence. Percutaneous cryoablation shows promise as a safe and effective treatment modality for recurrent thymoma.Entities:
Keywords: CTCAE; Common Terminology Criteria for Adverse Events (CTCAE)
Mesh:
Year: 2015 PMID: 25921453 DOI: 10.1016/j.jvir.2014.12.024
Source DB: PubMed Journal: J Vasc Interv Radiol ISSN: 1051-0443 Impact factor: 3.464